Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 19;37(5):606-615.
doi: 10.1093/fampra/cmaa043.

Faecal immunochemical test to triage patients with abdominal symptoms for suspected colorectal cancer in primary care: review of international use and guidelines

Affiliations

Faecal immunochemical test to triage patients with abdominal symptoms for suspected colorectal cancer in primary care: review of international use and guidelines

Marije van Melle et al. Fam Pract. .

Abstract

Background: Recently, faecal immunochemical tests (FITs) have been introduced for investigation of primary care patients with low-risk symptoms of colorectal cancer (CRC), but recommendations vary across the world. This systematic review of clinical practice guidelines aimed to determine how FITs are used in symptomatic primary care patients and the underpinning evidence for these guidelines.

Methods: MEDLINE, Embase and TRIP databases were systematically searched, from 1 November 2008 to 1 November 2018 for guidelines on the assessment of patients with symptoms suggestive of CRC. Known guideline databases, websites and references of related literature were searched. The following questions were addressed: (i) which countries use FIT for symptomatic primary care patients; (ii) in which populations is FIT used; (iii) what is the cut-off level used for haemoglobin in the faeces (FIT) and (iv) on what evidence are FIT recommendations based.

Results: The search yielded 2433 publications; 25 covered initial diagnostic assessment of patients with symptoms of CRC in 15 countries (Asia, n = 1; Europe, n = 13; Oceania, n = 4; North America, n = 5; and South America, n = 2). In three countries (Australia, Spain and the UK), FIT was recommended for patients with abdominal symptoms, unexplained weight loss, change in bowel habit or anaemia despite a low level of evidence in the symptomatic primary care patient population.

Conclusions: Few countries recommend FITs in symptomatic patients in primary care either because of limited evidence or because symptomatic patients are directly referred to secondary care without triage. These results demonstrate a clear need for research on FIT in the symptomatic primary care population.

Keywords: Cancer; cancer care/oncology; colorectal; diagnostic tests; endoscopy; primary care; screening.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
PRISMA flow diagram.

References

    1. International Agency for Research on Cancer. Colorectal Cancer-Globocan 2018. Lyon, France: The Global Cancer Observatory, 2019.
    1. McPhail S, Johnson S, Greenberg D, Peake M, Rous B. Stage at diagnosis and early mortality from cancer in England. Br J Cancer 2015; 112 (suppl 1):S108–15. - PMC - PubMed
    1. Office for National Statistics. Cancer Survival by Stage at Diagnosis for England (Experimental Statistics): Adults Diagnosed 2012, 2013 and 2014 and Followed Up to 2015. Office for National Statistics.2016.
    1. Neal RD, Tharmanathan P, France B et al. Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review. Br J Cancer 2015; 112 (suppl 1):S92–107. - PMC - PubMed
    1. National Institute for Health and Care Excellence (NICE). Quantitative Faecal Immunochemical Tests to Guide Referral for Colorectal Cancer in Primary Care[DG30] [Internet]. 2017. https://www.nice.org.uk/guidance/dg30/chapter/1-Recommendations (accessed on 11 December 2018).

Publication types